AI AMIOKA

Last Updated :2025/12/18

Affiliations, Positions
Hiroshima University Hospital, Assistant Professor
E-mail
amokai09hiroshima-u.ac.jp

Basic Information

Major Professional Backgrounds

  • 2009/04/01, 2011/03/31, Hiroshima University, Hospital, Medical Resident
  • 2011/04, 2013/03, Hiroshima City Asa Citizens Hospital
  • 2013/04/01, 2014/03/31, Hiroshima University, Hospital, Medical Doctor
  • 2014/04, 2016/06, HIROSHIMA KYORITSU HOSPITAL
  • 2016/07/01, 2017/03/31, Hiroshima University, Hospital, Medical Doctor
  • 2017/04, 2019/03, HIROSHIMA KYORITSU HOSPITAL
  • 2019/04/01, 2020/03/31, Hiroshima University, Hospital, Medical Doctor
  • 2020/04, 2023/03, Kure Kyosai Hospital
  • 2023/04/01, 2025/03/31, Hiroshima University, Hospital, Medical Doctor
  • 2025/04/01, Hiroshima University, Hospital, Assistant Professor

Educational Backgrounds

  • Hiroshima University, Graduate School of Biomedical & Health Sciences , Japan, 2014/04, 2021/08
  • Nippon Medical School, School of Medicine, Japan, 2003/04, 2009/03

Academic Degrees

  • Hiroshima University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;General surgery

Research Activities

Academic Papers

  1. Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy, Clinical Breast Cancer, 14(5), 358-364, 20140602
  2. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy, Japanese Journal of Clinical Oncology, 46(4), 303-309, 20160403
  3. Evaluation of Malignancy Grade of Breast Cancer Using Perflubutane-Enhanced Ultrasonography, Ultrasound Med Biol, 42(5), 1049-1057, 201605
  4. Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer, Oncotarget, 9(30), 20979-20992, 20180420
  5. ★, Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer., Breast Cancer, 28(5), 1062-1071, 20210528
  6. Dynamic changes of blood glucose level during capivasertib treatment in metastatic breast cancer: a case report, DIABETOLOGY INTERNATIONAL, 16(4), 851-854, 202510
    Link to Paper Search Results by DOI
  7. Prognostic value of FDG PET/CT in special types of breast cancer with non-favorable histology, DISCOVER ONCOLOGY, 16(1), 20250731
    Link to Paper Search Results by DOI
  8. Diagnostic performance of TILs-US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 29(12), 1860-1869, 202412
    Link to Paper Search Results by DOI
  9. Exploring the possibility of omitting axillary surgery in patients with clinical node-positive breast cancer achieving ypT0 after neoadjuvant chemotherapy, BREAST CANCER RESEARCH AND TREATMENT, 212(1), 47-56, 202507
    Link to Paper Search Results by DOI